Corresponding Author: Thomas S. Higgins, MD, MSPH, Department of Otolaryngology–Head and Neck Surgery and Communicative Disorders, University of Louisville School of Medicine, 6420 Dutchmans Pkwy, Ste 380, Louisville, KY 40205 (thomas.higgins@louisville.edu).
Published Online: September 17, 2020. doi:10.1001/jamaoto.2020.2946
Conflict of Interest Disclosures: Dr Higgins reported being a paid research investigator for Optinose and Gossamer and receiving personal fees from Sanofi-Regeneron and Genentech outside the submitted work. Dr Wu reported receiving payment for positions as a speaker for Sanofi-Regeneron and Optinose, a member of a medical advisory board for Optinose and Gossamer, and an investigator for Gossamer outside the submitted work. No other disclosures were reported.
1.Centers for Disease Control and Prevention. Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19: interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19). Coronavirus Disease 2019 (COVID-19) website. Accessed May 14, 2020.
https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html
5.Tunsjø
HS , Berg
AS , Inchley
CS , Røberg
IK , Leegaard
TM . Comparison of nasopharyngeal aspirate with flocked swab for PCR-detection of respiratory viruses in children.
APMIS. 2015;123(6):473-477. doi:
10.1111/apm.12375PubMedGoogle ScholarCrossref